Skip to Main Content
Services Talent Knowledge
Site Search
Menu

News

August 27, 2020

Linda Clark Published in America's Pharmacist

Linda Clark, Health Care Controversies Team leader, recently had her “A Tale of Two Courts: How Opioid Cases, Evolving During the COVID-19 Crisis, May Shape Pharmacist Liability and Best Practices” article published in the National Community Pharmacists Association’s America’s Pharmacist.

“Even as the world’s health care system faces the unprecedented challenges of the COVID-19 pandemic, opioid litigation continues its march through the legal system toward trial (Figure 1). These cases against drug companies, suppliers, and pharmacies are expected to yield important precedent that may broadly affect pharmacist liability and practices in the emerging post-COVID world.

The lawsuits have been filed by many different plaintiffs, including cities, counties, Native American tribes, and municipalities. More than 2,500 federal lawsuits have been brought against participants in the drug supply chain including pharmaceutical manufacturers, distributors, and retailers. The claims asserted seek reimbursement for governmental expenditures arising out of opioid addictions and overdoses. The defendants have included major pharmaceutical companies such as McKesson Corp., Cardinal Health, AmerisourceBergen, Purdue Pharma, Janssen Pharmaceuticals (a subsidiary of Johnson & Johnson), Endo International, Teva Pharmaceutical, Allergan (formerly Actavis), Watson Pharmaceuticals, and Covidien. Many of these cases have been consolidated into a combined case often referred to as the “MDL” or “Multidistrict Opioid Litigation” now pending before a US District Court in Cleveland, Ohio.”

Read the full article here.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

The New York FY 2025 Budget – CDPAP FIs Under Threat

Alerts

Website Accessibility Lawsuits: Several "Tester" Plaintiffs—Anderson, Beauchamp, Murray, Angeles, Monegro, and Bullock—Targeting Businesses in Recent Flurry of Lawsuits

Alerts

Updated Bulletin on Tracking Technologies in the Health Care Industry

Alerts

NYS Board of Regents Adopts Regulations on the Mental Health Diagnostic Privilege

Alerts

First Department Clarifies Pleading Requirements Under NYS Child Victims Act

Alerts

Beneficial Ownership Reporting Requirements Under the CTA: Quarterly Reminder

We're Growing in DC!

We’re excited to announce Barclay Damon’s combination with Washington DC–based Shapiro, Lifschitz & Schram. SLS’s 10 lawyers, three paralegals, and four administrative staff will join Barclay Damon while maintaining their current office in DC’s central business district. Our clients will benefit from SLS’s corporate, real estate, finance, and construction litigation experience and national energy-industry profile, and their clients from our full range of services.

Read More

This site uses cookies to give you the best experience possible on our site and in some cases direct advertisements to you based upon your use of our site.

By clicking [I agree], you are agreeing to our use of cookies. For information on what cookies we use and how to manage our use of cookies, please visit our Privacy Statement.

I AgreeOpt-Out